Onxeo conceives, develops, and registers innovative drugs for the treatment of orphan oncology diseases, an area with significant and unmet medical needs. The company is listed on both Euronext Paris and Nasdaq Copenhagen, which reflects its shareholder composition and the division of the company’s activities in the two countries.

Contact name:

Sarah Maria Wilkens


Fruebjergvej 3, 2100 Copenhagen, Denmark

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or 28895854

Copyright 2010 Danskbiotek. All rights reserved.